Many GS patients also develop neutralizing anti-cytokine autoantibodies to Type 1 interferons, IL-12, IL-17A/F, and IL-23, further weakening immune responses to various opportunistic and viral pathogens [9, 10]. The gene discussed is IL17A; the disease is Gerstmann syndrome.